menu
    • menu

    Company profile for Clarametyx Biosciences

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Clarametyx Biosciences is combating the formidable challenge of persistent antibiotic-resistant infections through an innovative technology platform that targets the biofilm—a protective layer around bacteria—to enable a more effective immune response or antibiotic intervention. The Columbus, Ohio-based company is building a dynamic pipeline of immune-enabling therapies and vaccines for chronic and recurrent bacterial infe...
    Clarametyx Biosciences is combating the formidable challenge of persistent antibiotic-resistant infections through an innovative technology platform that targets the biofilm—a protective layer around bacteria—to enable a more effective immune response or antibiotic intervention. The Columbus, Ohio-based company is building a dynamic pipeline of immune-enabling therapies and vaccines for chronic and recurrent bacterial infections associated with biofilms. Its lead candidate, CMTX-001, is a humanized monoclonal antibody in preclinical development for hospital-acquired pneumonia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clarametyx BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1275 Kinnear Road Columbus, OH 43212
    Telephone
    Telephone
    614.686.2689
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://clarametyx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clarametyx Bio Strengthens Leadership For Pipeline & Corporate
    Clarametyx Bio Strengthens Leadership For Pipeline & Corporate

    20 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-20/clarametyx-biosciences-strengthens-leadership-team-to-accelerate-pipeline-and-corporate-development

    PHARMIWEB
    20 Oct 2025
    Share Share
    Clarametyx Biosciences Completes Phase 2A Enrollment
    Clarametyx Biosciences Completes Phase 2A Enrollment

    16 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-16/clarametyx-biosciences-announces-completion-of-enrollment-in-phase-2a-study-of-cmtx-101-in-cystic-fi

    PHARMIWEB
    16 Oct 2025
    Share Share
    Clarametyx Biosciences Gets Fast Track, QIDP Tag for CMTX-101
    Clarametyx Biosciences Gets Fast Track, QIDP Tag for CMTX-101

    04 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250804750253/en/Clarametyx-Biosciences-Announces-FDA-Grant-of-Fast-Track-and-Qualified-Infectious-Disease-Product-Designations-for-CMTX-101

    BUSINESSWIRE
    04 Aug 2025
    Share Share
    Clarametyx Bio Announces Investment by Kineticos Accelerator Fund
    Clarametyx Bio Announces Investment by Kineticos Accelerator Fund

    28 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250128564757/en

    BUSINESSWIRE
    28 Jan 2025
    Share Share
    Clarametyx Wins CARB-X Deal To Advance Anti-Biofilm Vaccine
    Clarametyx Wins CARB-X Deal To Advance Anti-Biofilm Vaccine

    07 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250106643035/en

    BUSINESSWIRE
    07 Jan 2025
    Share Share
    Clarametyx Progresses Study On CMTX-101 Antibody Therapy
    Clarametyx Progresses Study On CMTX-101 Antibody Therapy

    17 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241015655882/en

    BUSINESSWIRE
    17 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search